Vitamin D Blood Test: Normal Levels, Deficiency & Results
The vitamin D blood test measures 25-hydroxy vitamin D. Learn normal vitamin D levels, why experts disagree on what counts as low, and who should be tested.
Vitamin D lets your gut absorb calcium, which puts it at the center of bone health. It's also unusual: your skin makes most of it from sunlight, and food supplies only a small share. The vitamin D blood test measures 25-hydroxy vitamin D — written 25(OH)D on your report — because it best reflects your stores. This guide covers what the test measures, normal vitamin D levels, what causes low vitamin D, and the part almost nobody explains honestly: experts genuinely disagree about where "low" begins, and that disagreement decides whether millions of Americans are called deficient or normal.
Key takeaways
- Vitamin D drives calcium absorption and bone mineralization. The test measures 25-hydroxy vitamin D (25-OH-D), the storage form.1
- There is no agreed cutoff for deficiency. The USPSTF states plainly that "no one serum vitamin D level cutpoint defines deficiency."2
- The IOM/NASEM concluded ≥ 20 ng/mL (50 nmol/L) meets the needs of at least 97.5% of people, and that above 30 ng/mL benefit is not consistent.3 The Endocrine Society's 2011 guideline set deficiency at < 20 ng/mL, insufficiency at 21–29, sufficiency at ≥ 30.4 In 2024 the Endocrine Society declined to define any threshold and now suggests against routine screening in healthy adults.56
- 1 ng/mL = 2.5 nmol/L. The U.S. reports ng/mL; most of the world uses nmol/L.34
- The USPSTF grades screening "I" — insufficient evidence — in asymptomatic adults;2 vitamin D is one of the most over-ordered tests in the country.7
- Low vitamin D is usually silent; deep, prolonged deficiency weakens bone and raises fall risk.8 But in healthy, non-deficient adults, supplementing does not reduce fractures or falls.91011
What is vitamin D, and what does the test measure?
Vitamin D is fat-soluble. Its central job is to let your intestine absorb calcium and phosphorus, which keeps bone mineralized and strong; it also supports muscle function. Its peculiarity is that it's barely a vitamin at all — your skin manufactures it from UVB rays, and diet contributes only a modest fraction.
The blood test doesn't measure the vitamin D you swallowed or made. It measures 25-hydroxy vitamin D — the form your liver converts it into, which circulates for weeks and therefore reflects your reserves.1 Your report may call it 25(OH)D, 25-hydroxyvitamin D, or calcidiol. The active hormone form (1,25-dihydroxy vitamin D) is not used to assess vitamin D status in ordinary practice. It's interpreted alongside calcium, PTH (parathyroid hormone), and phosphate, which together regulate calcium in your body. No fasting is needed: "You don't need any special preparations for a vitamin D test."1
Why is vitamin D measured — and should you be tested?
The USPSTF gives vitamin D screening an "I" statement. In 2021, reviewing asymptomatic, community-dwelling, nonpregnant adults, it concluded that "the current evidence is insufficient to assess the balance of benefits and harms of screening for vitamin D deficiency in asymptomatic adults."2 An "I" grade is not an endorsement — it means nobody can tell you whether screening helps you. Their reasoning: screening "may misclassify persons," because of "the uncertainty about the cutoff for defining deficiency and the variability of available testing assays," and that misclassification "may result in overdiagnosis (leading to nondeficient persons receiving unnecessary treatment)."2
Meanwhile the test keeps getting ordered. 25-hydroxyvitamin D testing "has increased in recent years despite recommendations against routine testing by multiple national guidelines and the Choosing Wisely Initiative," and inappropriate testing "can result in a delay in appropriate treatment, overdiagnosis, and unnecessary downstream cascades."7 Direct-to-consumer lab panels push it hard — worth knowing before you pay.
Testing makes sense when there's a reason — osteomalacia, rickets, osteoporosis or low bone density, a fracture or repeated falls; bone pain or muscle weakness; malabsorption (celiac disease, inflammatory bowel disease, bariatric surgery); chronic kidney disease or liver disease; risk factors such as little sun exposure, darker skin, older age or obesity; or monitoring an existing supplement regimen.14 If you're a healthy adult with no symptoms and no risk factors, neither the USPSTF nor the 2024 Endocrine Society guideline supports testing you.25
Normal vitamin D levels
Here's the distribution of actual American 25(OH)D levels, from NHANES 2011–2014, as reported in the evidence review commissioned by the USPSTF:1213
| 25(OH)D level | Share of U.S. population (age 1+) |
|---|---|
| < 12 ng/mL (< 30 nmol/L) | 5% |
| 12 – 19 ng/mL (30 – 49 nmol/L) | 18% |
| 20 – 50 ng/mL (50 – 125 nmol/L) | 73% |
| > 50 ng/mL (> 125 nmol/L) | 4% |
Units — read this once. The U.S. reports 25(OH)D in ng/mL (nanograms per milliliter); most other countries use nmol/L (nanomoles per liter). 1 ng/mL = 2.5 nmol/L — so 20 ng/mL = 50 nmol/L, 30 ng/mL = 75 nmol/L, 50 ng/mL = 125 nmol/L, the exact pairings both the IOM and the Endocrine Society print in their own documents.34 Compare your result to a foreign source without converting and you'll misread it by a factor of 2.5.
Notice what that table does not contain: a column labeled "normal." That omission is deliberate, and it's the honest heart of this test.
Why experts disagree on what "low" means
Most articles give you one set of numbers and move on. There isn't one set — there are two, and the body that authored the stricter one has since walked away from it.
| Source | Position on 25(OH)D |
|---|---|
| IOM / NASEM (2011) | ≥ 20 ng/mL (50 nmol/L) meets the needs of at least 97.5% of people; 16 ng/mL (40 nmol/L) meets about half; above 30 ng/mL (75 nmol/L) benefit is not consistent; above 50 ng/mL (125 nmol/L), concern for adverse effects3 |
| Endocrine Society (2011) | Deficiency < 20 ng/mL; insufficiency 21–29 ng/mL; to maximize effects on calcium, bone and muscle, levels should be above 30 ng/mL4 |
| Endocrine Society (2024) | Declines to set any threshold. "25(OH)D levels that provide outcome-specific benefits have not been established in clinical trials"56 |
| USPSTF (2021) | "No one serum vitamin D level cutpoint defines deficiency"2 |
So why the gap? Because the two 2011 documents answered different questions.
The IOM was setting Dietary Reference Intakes — a population nutrition standard. Its question: what level covers the bone health needs of essentially everybody? Its answer, 20 ng/mL, is chosen so that 97.5% of the population is covered. The committee refused to go higher because the evidence didn't support it: concentrations above 30 ng/mL "are not consistently associated with increased benefit."3 The Endocrine Society in 2011 was instead writing a clinical practice guideline for treating patients — an individual-level question, aimed at people already at risk — and set sufficiency at 30 ng/mL to maximize the effect on calcium and bone rather than merely to avoid deficiency.4
A population floor and an individual optimum are not the same object, and the 10 ng/mL between them is where tens of millions of Americans live. The IOM said so directly: the prevalence of vitamin D inadequacy in North America has been "overestimated by some groups due to the use of inappropriate cut-points that greatly exceed the levels identified in this report."3
Then the ground shifted. In 2024 the Endocrine Society declined to define thresholds at all: the panel found that "25(OH)D levels that provide outcome-specific benefits have not been established in clinical trials," and now suggests against routine screening in healthy adults.56 The stricter of the two positions was retired by the body that created it.
What this means for you. Draw the line at 20 ng/mL and roughly 23% of Americans fall below it; draw it at 30 ng/mL and you sweep in most of that 73% band too — the majority of the country becomes "insufficient" overnight. Same blood, same people; the threshold alone decides. Practically:
- Below 12 ng/mL — everybody agrees this is genuine deficiency, the range linked to rickets and osteomalacia. It needs medical attention.
- 12–20 ng/mL — the IOM places at least part of this band at risk of inadequacy. Worth a conversation, especially with risk factors.
- 20–30 ng/mL — the honest gray zone. The IOM says you're fine; the 2011 Endocrine Society criteria call you insufficient; the 2024 Endocrine Society declines to say. If a supplement seller calls this range a deficiency requiring their product, that's a contested claim, not a fact.
- Above 30 ng/mL — no consistent evidence of added benefit from going higher.3
Always compare your number to the range printed on your report: assay variability between laboratories is real.12
Interpreting your results
Low vitamin D: causes and symptoms
Low vitamin D is common and usually silent — which is why it gets found on tests rather than in clinics. When deficiency is deep and prolonged, it can cause bone and muscle pain, muscle weakness, and demineralization of bone — osteomalacia in adults, rickets in children — and in older adults it contributes to falls.
Risk factors are mostly about skin and sunlight: limited sun exposure, darker skin (melanin reduces UVB-driven synthesis), older age, obesity (vitamin D is sequestered in fat), northern latitudes and winter, plus digestive disease that impairs absorption. Deficiency often travels with other nutritional gaps, so it may be checked alongside markers like vitamin B12.
Now the finding that reframes everything: in healthy adults who are not deficient, supplementing does not help your bones. The VITAL trial (~26,000 U.S. adults) found no reduction in fractures9 and no reduction in falls;10 Australia's D-Health trial (~21,000 adults aged 60–84, 60,000 IU monthly for five years) found no reduction in overall fracture risk.11 Vitamin D remains genuinely useful for people who are actually deficient — the argument for treating those who need it, not supplementing everyone and calling it prevention.
High vitamin D and toxicity
Excess vitamin D essentially never comes from sun or food — it comes from unsupervised high-dose supplementation. The IOM flagged > 50 ng/mL (125 nmol/L) as the level that should "raise concerns among clinicians about potential adverse effects."3 Frank hypervitaminosis D, above 150 ng/mL, is considered toxic.14 The harm comes through hypercalcemia — too much calcium in the blood — which can be serious.15 That's why "more must be better" fails for this vitamin: it's fat-soluble, it accumulates, and it has a ceiling.
Sun, food, and supplements
- Sun is the main source. Brief exposure of arms and face a few times a week supports synthesis — without burning. At northern latitudes in winter, UVB is too weak for meaningful production however long you stand outside.
- Food contributes modestly: fatty fish (salmon, mackerel, herring, sardines), egg yolk, and fortified milk, cereals, and orange juice. Diet alone rarely covers needs.
- Supplements work, and the format matters: the 2024 Endocrine Society guideline favors daily, lower-dose vitamin D instead of non-daily, higher-dose vitamin D for adults 50+ with an indication for treatment.516 Low-dose vitamin D is over the counter; the dose that treats a real deficiency is your clinician's call.15
Recent research
According to PubMed and major clinical guidelines:
- Guidance moved toward less testing and less blanket supplementing. The Endocrine Society's 2024 guideline suggests against routine 25(OH)D screening in healthy adults and against routine supplementation in adults aged 50–74, while suggesting empiric supplementation for children and adolescents (1–18), adults 75+ (potential mortality benefit), pregnancy, and high-risk prediabetes.5616 (Demay MB et al., JCEM, 2024 — DOI.)
- No bone benefit in the general population, per VITAL910 and D-Health11 above. (LeBoff MS et al., NEJM, 2022 — DOI; Waterhouse M et al., Lancet Diabetes Endocrinol, 2023 — DOI.)
- The controversy is unresolved, a century after vitamin D's discovery — over thresholds and over benefits beyond bone.8 Overuse is meanwhile a recognized quality problem.7 (Gallagher JC, Rosen CJ, Lancet Diabetes Endocrinol, 2023 — DOI; Cho HJ et al., J Gen Intern Med, 2023 — DOI.)
These findings concern screening and supplementation; they do not authorize self-medication and do not replace your physician's advice.
Get your vitamin D interpreted by AI DiagMe
A vitamin D level is never read alone: its meaning depends on your calcium, your PTH, and your context — season, skin tone, age, weight, medications, and which threshold your lab happens to print. The same 25 ng/mL is "fine" under one standard and "insufficient" under another. That cross-referencing is what gives the number its real value.
👉 AI DiagMe interprets your lab results — blood, urine, or stool — in plain language, taking your whole profile into account. An informational service that does not provide a diagnosis and complements, never replaces, your physician.
Frequently asked questions
What is a normal vitamin D level?
What is considered low vitamin D?
How do I convert nmol/L to ng/mL?
Should I get a vitamin D test?
What are the symptoms of vitamin D deficiency?
Can you take too much vitamin D?
Should I take vitamin D every day or in big weekly doses?
Bottom line
The vitamin D blood test measures 25-hydroxy vitamin D, the gauge of your reserves. The thing to hold onto isn't a "normal range" — it's that there isn't an agreed one. The IOM says 20 ng/mL (50 nmol/L) covers almost everyone; the 2011 Endocrine Society said 30; the 2024 Endocrine Society named no figure and now advises against routine screening; the USPSTF says no cutpoint defines deficiency at all. Remember 1 ng/mL = 2.5 nmol/L, that deficiency is usually silent, that supplementing non-deficient people doesn't prevent fractures, and that the real danger lies in unsupervised high doses. No value is read alone — what matters is your whole profile, which is what AI DiagMe provides, alongside your physician.
Sources
Official sources and peer-reviewed publications (PubMed, USPSTF, NCBI Bookshelf) used for this guide:
Footnotes
-
MedlinePlus (U.S. National Library of Medicine, NIH) — Vitamin D Test. medlineplus.gov ↩ ↩2 ↩3 ↩4
-
US Preventive Services Task Force. Screening for Vitamin D Deficiency in Adults: US Preventive Services Task Force Recommendation Statement. JAMA, 2021;325(14):1436-1442. Grade I statement. PubMed · DOI · uspreventiveservicestaskforce.org ↩ ↩2 ↩3 ↩4 ↩5 ↩6
-
Ross AC, Manson JE, Abrams SA, et al. The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know. J Clin Endocrinol Metab, 2011. PubMed · DOI ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8
-
Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab, 2011;96(7):1911-1930. PubMed · DOI ↩ ↩2 ↩3 ↩4 ↩5 ↩6
-
Demay MB, Pittas AG, Bikle DD, et al. Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab, 2024. PubMed · DOI ↩ ↩2 ↩3 ↩4 ↩5 ↩6
-
Endocrine Society — Vitamin D for the Prevention of Disease (clinical practice guideline, 2024): recommendation against routine 25(OH)D screening in healthy adults; daily lower-dose preferred over non-daily higher-dose. endocrine.org ↩ ↩2 ↩3 ↩4
-
Cho HJ, Mestari N, Israilov S, et al. Reducing 25-Hydroxyvitamin D Testing in a Large, Urban Safety Net System. J Gen Intern Med, 2023;38(10):2326-2332. PubMed · DOI ↩ ↩2 ↩3
-
Gallagher JC, Rosen CJ. Vitamin D: 100 years of discoveries, yet controversy continues. Lancet Diabetes Endocrinol, 2023. PubMed · DOI ↩ ↩2
-
LeBoff MS, Chou SH, Ratliff KA, et al. Supplemental Vitamin D and Incident Fractures in Midlife and Older Adults (VITAL). N Engl J Med, 2022. PubMed · DOI ↩ ↩2 ↩3
-
LeBoff MS, Murata EM, Cook NR, et al. VITamin D and OmegA-3 TriaL (VITAL): Effects of Vitamin D Supplements on Risk of Falls in the US Population. J Clin Endocrinol Metab, 2020. PubMed · DOI ↩ ↩2 ↩3
-
Waterhouse M, Ebeling PR, McLeod DSA, et al. The effect of monthly vitamin D supplementation on fractures: a tertiary outcome from the population-based, double-blind, randomised, placebo-controlled D-Health trial. Lancet Diabetes Endocrinol, 2023. PubMed · DOI ↩ ↩2 ↩3
-
Kahwati LC, LeBlanc E, Weber RP, et al. Screening for Vitamin D Deficiency in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA, 2021. PubMed · DOI · NCBI Bookshelf NBK569726 ↩ ↩2
-
Herrick KA, Storandt RJ, Afful J, et al. Vitamin D status in the United States, 2011-2014. Am J Clin Nutr, 2019;110(1):150-157. PubMed · DOI ↩
-
Sizar O, Khare S, Goyal A, Givler A. Vitamin D Deficiency. StatPearls, NCBI Bookshelf, 2023. Bookshelf ID NBK532266. bookshelf ↩
-
Aberger S, Schreiber N, Pilz S, et al. Targeting Calcitriol Metabolism in Acute Vitamin D Toxicity — A Comprehensive Review and Clinical Insight. Int J Mol Sci, 2024. PubMed · DOI ↩ ↩2
-
Shah VP, Nayfeh T, Alsawaf Y, et al. A Systematic Review Supporting the Endocrine Society Clinical Practice Guidelines on Vitamin D. J Clin Endocrinol Metab, 2024. PubMed · DOI ↩ ↩2